Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib in metastatic/recurrent or unresectable GIST after imatinib failure
CTR20132418Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famitinib in gastrointestinal stromal tumor (GIST), sponsored by Hengrui Therapeutics. Started Mar 2014; status: active.
02
Drugs
famitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on CTR20132418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132418.